Psilocybin Extends Lifespan in Aged Mice, Preserves Telomeres in Human Cells

Bottom line: Aged mice given psilocybin lived longer, and human cells treated with psilocin — the active metabolite — showed a 28.5% increase in lifespan. This is the first evidence that psilocybin might slow aging at the cellular level.

A mouse in a lab lived longer than it would have — not by chance, but because of psilocybin. A 2025 study in npj Aging shows that this compound, once known only for its hallucinogenic effects, may also slow aging. The results are preliminary, but they’ve shifted the conversation about aging from something inevitable to something that could be mitigated.

This study didn’t look at mental health, like previous trials have. It asked a different question: could psilocybin slow aging at the cellular level? And if so, how?

A Cellular Time Machine: Psilocin and Telomere Preservation

The first clue came from human cells. Researchers exposed aged human fibroblasts — the cells in connective tissue — to psilocin, the active form of psilocybin. These cells, which typically lose function with age, gained a lifeline: their lifespan increased by about 8.3 population doublings, roughly a 28.5% extension. That’s more than most compounds achieve in cultured cells.

Even more interesting: psilocin preserved telomere length. Telomeres are the caps at the ends of chromosomes that shorten with each cell division. When they get too short, cells stop dividing — a key part of aging. By preserving telomeres, psilocin may be delaying the point at which cells stop working.

Telomere preservation is a major goal in aging research. If psilocin can mimic the effects of telomerase — the enzyme that rebuilds telomeres — without the risks of artificially activating it, it could be a big deal.

Aged Mice Live Longer: Geroprotective Potential

The next step was to test psilocybin in whole organisms. Researchers used aged mice, a model that closely mirrors human aging. Mice given psilocybin showed better survival rates than those in the control group.

The results weren’t dramatic, but they were consistent. Psilocybin didn’t reverse aging in these mice, but it did slow its progression. The authors called this effect “geroprotective” — meaning it protects against aging-related damage.

The proposed mechanism has two parts: psilocybin may reduce oxidative stress, and it may preserve telomeres. Oxidative stress comes from free radicals that damage cells. Psilocybin may be giving cells a better chance to survive longer by reducing that damage.

A New Framework for Psychedelic Rejuvenation

A related paper in OpenAlex suggests a “Psychedelic Rejuvenation Hypothesis.” It argues that psilocybin may not only treat mental illness but also help the body stay youthful. The hypothesis is based on studies showing that these compounds affect aging pathways — like neuroplasticity, inflammation, mitochondrial function, and telomere dynamics.

This isn’t the first time scientists have drawn parallels between stress and longevity. Exercise, for instance, is a hormetic stressor — it stresses the body just enough to trigger adaptive responses that make it stronger. The authors say psychedelics may work similarly, pushing the body to adapt in ways that improve longevity.

The surprising part is the role of psychological benefits. Psychedelics increase openness and emotional flexibility, and reduce stress — all of which are linked to better health. These changes may influence aging through complex neural and hormonal pathways.

Frequently Asked Questions

What does the study say about telomere length in human cells?
The study found that psilocin helped preserve telomere length in aged human fibroblasts. This could be a key mechanism by which psilocybin may slow aging.

Does this mean psilocybin can extend human lifespan?
Not yet. The study was conducted in cultured human cells and aged mice, not in humans. More research is needed before any conclusions can be drawn about human aging.

What is a geroprotective agent?
A geroprotective agent is a substance that protects against biological aging by reducing damage to cells and tissues. Psilocybin may act as one by reducing oxidative stress and preserving telomeres.

What are the limitations of the study?
The study was preclinical, meaning it was conducted in cells and mice, not in humans. The sample sizes were small, and the long-term safety of psilocybin was not explored.

Could psilocybin be used as a preventive medicine?
The study suggests that psilocybin may have potential as a geroprotective agent, but this is only one piece of the puzzle. More research is needed to understand its role in preventing aging in humans.

Sources

• ¶Kato, Kleinhenz, Shin et al. (2025). Psilocybin treatment extends cellular lifespan and improves survival of aged mice. npj Aging
• ¶Psilocybin treatment extends cellular lifespan and improves survival of aged mice. Europe PMC
• ¶Psilocybin and human longevity. npj Aging
• ¶Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration. OpenAlex

Educational Disclaimer

This article is for informational and educational purposes only. It is not medical advice, mental health advice, diagnosis, treatment guidance, or a recommendation to use any substance, supplement, therapy, or protocol.

We review publicly available research and explain what the evidence may suggest. Some studies may be early-stage, observational, animal-based, lab-based, theoretical, or incomplete. Always consult a qualified professional before making health-related decisions.

Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.